Cargando…
Fewer Functional Deficits and Reduced Cell Death after Ranibizumab Treatment in a Retinal Ischemia Model
Retinal ischemia is an important factor in several eye disorders. To investigate the impact of VEGF inhibitors, as a therapeutic option, we studied these in a retinal ischemia animal model. Therefore, animals received bevacizumab or ranibizumab intravitreally one day after ischemia induction. Via el...
Autores principales: | Palmhof, Marina, Lohmann, Stephanie, Schulte, Dustin, Stute, Gesa, Wagner, Natalie, Dick, H. Burkhard, Joachim, Stephanie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032266/ https://www.ncbi.nlm.nih.gov/pubmed/29857531 http://dx.doi.org/10.3390/ijms19061636 |
Ejemplares similares
-
Microglia Activation in Retinal Ischemia Triggers Cytokine and Toll-Like Receptor Response
por: Wagner, Natalie, et al.
Publicado: (2020) -
Protective effects on the retina after ranibizumab treatment in an ischemia model
por: Joachim, Stephanie C., et al.
Publicado: (2017) -
From Ganglion Cell to Photoreceptor Layer: Timeline of Deterioration in a Rat Ischemia/Reperfusion Model
por: Palmhof, Marina, et al.
Publicado: (2019) -
Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
por: Renner, Marina, et al.
Publicado: (2017) -
Comparable effects on tear film parameters after femtosecond laser-assisted and conventional cataract surgery
por: Schargus, Marc, et al.
Publicado: (2020)